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ABSTRACT
Aesculus hippocastanum L. is a native tree of Asia. Its leaves, seeds and flowers have long been used in folk medicine and in traditional food ingredients. In this study, the bark, seeds, leaves and flowers as aerial parts of A. hippocastanum were extracted in ethanol. The
antioxidant capacity of each part was determined for its 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) scavenging capacity, microsomal
lipid peroxidation inhibition capacity and total phenolic content. Among all the parts examined, the bark extract of A. hippocastanum
revealed the highest antioxidant capacity with an IC50 value of 0.025 mg/mL and 0.014 mg/mL for the inhibition of lipid peroxidation
and for the scavenging of DPPH radical, respectively. The bark extract was further examined for its cytotoxic effect on human breast
cancer cells (MCF-7) and on healthy cells (3T3) using the MTT method. Cell viability was reduced to 30% upon the addition of
0.5 mg/mL bark extract for both cell lines.
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INTRODUCTION
The Aesculus species in the family of Hippocastanaceae have found its use as a food supplement. After certain
treatments, the seeds of Aesculus turbinate B. were used as
ingredients in traditional foods and as constituents of herbal
drugs in Japan(1).
Extracts of A. hippocastanum have been widely used for
the treatment of chronic venous insufficiency(2-6). In particular, the seeds are used for the treatment of hemorrhoids,
topical ulcers and cancer(7-9). The commonly known active
component in the seeds, β-escin (aescin), was suggested to
have anti-carcinogenic activity(10). Reparil(11) and Venostatin(12,13) are some of the drugs with aescin as the active
ingredient and are known for anti-inflammatory, anti-oedematous(14-16) and anti-exudative activities(17).
Traditionally, the seeds, leaves and bark were used
in medicinal and cosmetic preparations(18-20). The bark
and leaves were used for their analgesic and astringent
effects(21,22). The leaves have also been used in the treatment of arthritis and as a cough remedy(8). A. hippocastanum
* Author for correspondence. Tel: 90-312-210-51-39;
Fax: 90-312-210-32-00; E-mail: ncoruh@metu.edu.tr

was quite effective against brain trauma and stroke, venous
congestion(8,21,23,24) and thrombophlebitis(25).
Many of the beneficial effects of medicinal plants are
attributed to their high polyphenolic content. These molecules are proposed to reduce cellular oxidative stress, which
plays an important role in the pathogenesis of a number of
diseases including cancer and cardiovascular diseases. In
this study, the antioxidant activities of ethanolic extracts of
A. hippocastanum parts (bark, seeds, leaves and flowers)
were investigated by the methods of microsomal lipid peroxidation inhibition and DPPH radical scavenging, as well as the
total phenolic content. The bark extract exhibited the highest
antioxidant capacity. Therefore, further examination for cytotoxic effect was carried out against human breast cancer cells
(MCF-7) using healthy cells (3T3) as a control.

MATERIALS AND METHODS
I. Chemicals
Ethylene diamine tetraacetic acid (EDTA), glycerol,
bovine serum albumin (BSA), copper sulfate (CuSO4),
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sodium potassium tartrate, sodium hydroxide (NaOH),
sodium carbonate (Na2CO3), hydroxy methyl aminomethane
(Tris), hydrochloric acid (HCl), iron salt (Fe2SO4·7H2O),
glycerol, thiobarbituric acid (TBA), ortho phosphoric acid
(H3PO4) alpha-tocopherol, 1,1-diphenyl-2-picrylhydrazyl
radical (DPPH), gallic acid, quercetin, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphentyltetrazolium bromide (MTT) and
RPMI-1640 were purchased from Sigma (St. Louis, MO,
USA). Dimethyl sulphoxide (DMSO) and Ciocalteu`s Folin
phenol reagent were purchased from Merck (Darmstadt,
Germany). Fetal bovine serum (FBS) and Dulbecco’s Modified Eagle’s Medium with L-glutamine (DMEM/Ham’s F12)
were purchased from Biochrome AG (Germany). Isopropyl
alcohol was purchased from Applichem (Germany). All
other chemicals were of analytical grade and obtained from
commercial sources at the highest purity available.
Human breast epitheloid adenocarcinoma cell line
MCF-7 and 3T3 healthy fibroblastic cells were obtained from
HUKUK Culture Collection (Institute of Foot and Mouth
Disease, Turkey).
II. Plant Materials
Flower, leaf, seed and bark samples from A. hippocastanum were collected from the campus forestry of the Middle
East Technical University in Ankara, Turkey in their appropriate seasons and the specimens were deposited in the Department of Chemistry. The plant specimens with their localities
and the necessary field records were written and enumerated.
They were pressed, dried according to herbarium techniques
and identified in accordance with the Flora of Turkey(26).
III. Preparation of Plant Extracts
The collected plant specimens were air dried and ground
using a Waring blender. Five grams of samples (in duplicates)
were extracted in ethanol at 50°C for 24 h with a sample-tosolvent ratio of 1:10 (w/v). The crude extracts were filtered
and dried under vacuum at 50°C using a rotary evaporator
(Heidolph Laborota 4000). The resulting extracts were
dissolved in suitable solvents for further studies. All samples
were kept at 4°C until use.

V. Lipid Peroxidation Inhibition Activity by Thiobarbituric
Acid Test
Microsomal lipid peroxidation was evaluated by the
thiobarbituric acid (TBA) test using the method of Ohkawa,
Ohishi & Yagi(29) with some modifications(30). Lipid peroxidation was induced with 100 mM of ferrous sulphate solution
(Fe2SO4·7H2O), in 0.2 M of Tris-HCl buffer at pH of 7.4.
Malonedialdehyde (MDA), the end product of lipid peroxidation, reacts with thiobarbituric acid (TBA) in acidic medium
upon boiling and the resulting MDA-TBA adduct absorbed at
532 nm, which was monitored by a UV-VIS spectrophotometer (Cary 50 Bio).
The MDA values were calculated using the extinction
coefficient 1.56 × 105 M-1 cm-1 and expressed as nmol/mg of
protein. Alpha-tocopherol was used as the positive control.
Microsomal lipid peroxidation inhibition was expressed as
lipid peroxidation inhibition in percentage or as fifty percent
inhibitory concentration IC50.
Lipid peroxidation inhibition (%) = [(OD532control 532
OD sample) ⁄ OD532control] × 100
where OD532 control is
the absorbance of control with ethanol and OD532sample is the
absorbance of the extracts dissolved in ethanol. IC50 values
were calculated after constructing the lipid peroxidation inhibition (%) versus log (extract concentration) curve and using
forecast function of Microsoft Excel.
VI. DPPH Radical Scavenging Activity
A free radical forms a stable molecule by accepting an
electron or hydrogen radical. Depletion of the stable radical
1,1-diphenyl-2-picrylhydrazyl (DPPH) in the solution reveals
the radical scavenging capacity of the antioxidant molecule.
This event was monitored by a decrease in absorption at
517 nm after 5, 10 and 30 min of reaction. One point four
milliliters of 0.05 mg/mL of DPPH solution in ethanol and
0.1 mL of each extract were mixed and the reaction mixture
was shaken vigorously. After 5 min of optimized reaction
period, the depletion of DPPH was followed by a decrease in
absorbance at 517 nm(31). The radical scavenging activity in
percentage was obtained from the following equation:
Radical scavenging activity (%) = [(OD517control ⁄ OD517control] × 100

IV. Isolation of Sheep Liver Microsomes

OD517sample)

Microsomes used for lipid peroxidation study were
obtained from the liver of slaughtered sheeps. Sheep livers,
obtained fresh from the slaughterhouse of Kazan-Ankara,
were homogenized with teflon glass attached to a multi-speed
drill (Black and Decker, V850) in 20 mM of Tris-HCl (pH
7.4) containing 1.15% KCl (w/v), 1.0 mM of ethylenediaminetetraacetic acid (EDTA) and 1.0 mM of dithiothreitol
(DTT), and centrifuged by Sorvall RC 5C Plus with SS-34
rotor at 10,800 ×g for 25 min and Sorvall Combi Plus Ultracentrifuge at 133,573 ×g for 50 min(27). The protein content
of the microsomal suspension was measured by Lowry’s
method(28).

The radical scavenging capacity was also expressed
as the amount of scavenging material necessary to decrease
the initial DPPH concentration by 50% (IC50) and calculated by plotting radical scavenging capacity (%) versus
log [extract concentration] and using the built-in function,
forecast, in Microsoft Excel.
VII. Determination of the Total Amount of Polyphenolics
The total amount of polyphenolics found in the extracts
were determined through the method of Singleton and
Rossi(32). A volume of 0.1 mL of each extract or gallic acid
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solution was mixed with 2.0 mL of 2% Na2CO3 aqueous
solution. After 3 min, 0.1 mL of 50% Folin-Ciocalteu’s
phenol reagent was added. Absorbance was monitored at 750
nm and the results were expressed as Gallic Acid Equivalents (GAE), that is, milligrams of gallic acid-like phenolic
compounds per milligram of extract.

where OD570 treated cells is the absorbance for the cells
treated with different extract concentrations and OD570 control
cells is the absorbance for the cells treated with 1% DMSO
concentration at 570 nm.

VIII. Cell Culture and Treatments

All results are expressed as mean±standard deviation
(SD). The statistical Q-test was used for deciding whether a
suspected result should be retained or rejected.
Significant differences between the two sample means
were checked by the of t test statistic and compared with
the critical value of t obtained from statistical tables at 95%
confidence level.

Cell cultures were obtained from HUKUK Culture
Collection (Institute of Foot and Mouth Disease, Turkey)
and they were allowed to grow in laminar flow chambers
(Class II Holten, Denmark). HUKUK/3T3 and MCF-7
human breast epitheloid adenocarcinoma cell line were
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
with L-glutamine, containing 10% fetal bovine serum (FBS),
1% sodium carbonate and 10 µg/mL of gentamicin. The
cells were passaged for 3 subcultures and seeded in T25 cell
culture flasks (25 cm2) at 37°C under a humidified 5% carbon
dioxide (Heracell incubator, Germany). A suspension of cells
was prepared in DMEM medium (2.5 × 104 cells/mL) and a
100 mL aliquats were added into each well of 96-well culture
plates. After 24 h of incubation at 37°C, the cells were examined under an inverted cell culture microscope (Olympus,
CK40, Japan) for growth and sterility. The medium was
aspirated and the cells were treated with 100 mL/well of
different concentrations of A. hippocastanum bark ethanol
extract (0.01-0.5 mg/mL). Dry bark extracts were dissolved
in DMSO before their application on cell cultures. The effect
of the concentration of DMSO was examined as the negative
control. The control data exhibited no effect on proliferation
of either cell types, up to 1% of DMSO concentration. As a
result, 1% DMSO concentration was utilized for the dissolution of extracts before the application on the cells.
IX. MTT Cellular Cytotoxicity Bioassay
The tetrazolium salt of MTT is metabolized by mitochondrial succinic dehydrogenase activity of proliferating
cells to yield a purple reaction product and the assay was
performed as described in the method of Mosman(33). MTT
was prepared in phenol red contained RPMI-1640 with a final
concentration of 5 mg/mL. The media of cells which were
incubated for 24 h in 96-well plates were decanted and 100
mL of DMEM medium and 13 mL of MTT solution were
added to each well. After 4 h of incubation at 37°C in a
humidified 5% CO2 in the dark, the supernatant was removed
and replaced with 100 mL/well of isopropyl alcohol. The
absorbance value of each well was monitored at 570 nm by
a microplate reader device (Molecular Device Corp, USA)
and the results were compared with that of controls. The
results were determined by the average of three independent
experiments. The cell viability was calculated according to
the following equation:
Cell viability (%) = [OD570 treated cells ⁄ OD570 control cells]
× 100

X. Statistical Analysis

RESULTS
I. Yield of A. hippocastanum Extracts
Each 5 g of air-dried flower, seed, leaf and bark sample
were extracted in 50 mL of ethanol at 50°C using a rotary
evaporator. Extraction yields were in the range of 1.04-6.25%
(w/w). The results are shown in Table 1.
Sample collections for the parts of A. hippocastanum
were realized for two consecutive years during appropriate
seasons. Experimentation was arranged with at least two 5-g
samples and extraction was carried out in duplicate.
II. Lipid Peroxidation Inhibition Activity of A. hippocastanum
Extracts
Lipid peroxidation inhibition was used as one of the
methods to evaluate antioxidant capacity. Lipid peroxidation inhibition capacity of each extract was calculated in
percentage and the results are shown in Figure 1. The final
extract concentrations were prepared in the range of 0.05
mg/mL to 5 mg/mL during the lipid peroxidation inhibition
experiments.
Fifty percent inhibition of lipid peroxidation (IC50) was
calculated for each of the extract in mg/mL to compare their
antioxidant capacities, and the results are shown in Table 2.
The results indicated that the bark extract was a significantly more effective inhibitor of lipid peroxidation (p <
0.05), with an IC50 value of 0.025 mg/mL, compared to the
seeds, leaves, flowers and even a well-known antioxidant
standart, alpha-tocopherol (IC50 = 0.23 mg/mL).

Table 1. Ethanol extraction yields from the parts of A. hippocastanum
Parts
Bark

Yield of extract (mg)

Yield (%, w/w)

51.8 ± 14.1

1.04 ± 0.28

Seeds

103.8 ± 4.7

2.08 ± 0.09

Leaves

143.5 ± 31.1

2.87 ± 0.62

Flowers

312.5 ± 10.7

6.25 ± 0.22
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III. DPPH Radical Scavenging Activity of A. hippocastanum
Extracts
The free radical scavenging activity of A. hippocastanum part extracts were evaluated by using the DPPH radical
scavenging method. The results were plotted as the radical
scavenging activity (%) versus concentration of extracts (mg/
mL)(Figure 2) and the representative IC50 values are shown
in Table 2.
The bark extract of A. hippocastanum was found to be
a significantly more effective (p < 0.05) radical scavenger,
with an IC50 value of 0.014 mg/mL, compared to all the other
parts. The next effective extract was the seed, with an IC50
value of 0.168 mg/mL.
IV. Total Phenolic Contents of A. hippocastanum Extracts
The total polyphenolic amount of each extract was determined as the effective bioactive constituents and the results
are expressed in milligrams of gallic acid equivalents (GAE)

Floweres

Leaves

Bark

Seeds

Alpha-tocopherol

per milligram of extract in Table 2. The extracts of leaves
and bark revealed the highest amount of phenolics, 0.075
and 0.061 mg GAE/mg extract, respectively. The difference
between the two values was insignificant. The flower extract
was also considerably high in phenolic content (0.045 mg
GAE/mg extract).
V. Effect of Bark Extract on Cell 3T3 Healthy Fibroblasts and
MCF-7 Breast Cancer Cell Lines
Cytotoxicity studies were carried out using only the
bark extract justified by its remarkable antioxidative properties. The effects of A. hippocastanum bark extracts were
examined by monitoring the proliferation of breast cancer
(MCF-7) and healthy fibroblast (3T3) cells in the presence
of MTT solution.
At minimal concentrations of bark extract (0.01 mg/
mL), the viability of MCF-7 cancer cells decreased to 90%,
while that of 3T3 healthy fibroblast cells increased to 120%.
Moreover, a 0.1 mg/mL of bark extract addition exerted a
decrease on the viabilities of 3T3 and MCF-7 cells by 55 and
70%, respectively. Finally, about 30% of cell viabilities were
accomplished upon the addition of 0.5 mg/mL of bark extract
for both cell lines, as shown in Figure 3.

80

Floweres

60
40
20
0
0

1

2
3
Extract (mg/mL)

4

5

Figure 1. Lipid peroxidation inhibition of extracts of A. hippocastanum
flowers, leaves, seeds, bark and alpha-tocopherol as a control. 1.0 mg/
mL of microsomal suspension was used as the lipid source. Each data
was obtained from 6 to 9 independent measurements.

Radical Scavenging Activity (%)

Lipid Peroxidation Inhibition (%)

100
Seeds
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Quercetin

100
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0
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Figure 2. Free radical scavenging activity of A. hippocastanum part
extracts. Each data was obtained from 6 to 9 independent measurements.

Table 2. Antioxidant capacities and the amount of total phenolic content in A. hippocastanum ethanol extracts.
A. hippocastanum parts
Bark

Lipid peroxidation
IC50 (mg/mL)

DPPH radical
scavenging IC50 (mg/mL)

Total Phenolic Content
GAE (mg/mg extract)

0.025 ± 0.005*

0.014 ± 0.001*

0.061 ± 0.013

Seeds

0.886 ± 0.029

0.168 ± 0.074

0.021 ± 0.004

Leaves

0.666 ± 0.058

0.513 ± 0.017

0.075 ± 0.016

Flowers

3.103 ± 0.008

1.101 ± 0.061

0.045 ± 0.008

Alpha-tocopherol

0.230 ± 0.010

ND

NA

Quercetin
ND: not determined.

ND

0.009 ± 0.002

NA

NA: not applicable
*Significantly different data (p < 0.05). Statistical t-test was used to compare differences between means of different plant parts.
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Figure 3. Effect of ethanol bark extract concentrations (0.01-0.5 mg/
mL) on cell 3T3 healthy fibroblasts and MCF-7 breast cancer cell lines.

DISCUSSION
(21,34-36)

The presence of phenolic compounds
in A.
hippocastanum had been reported in literature. The antioxidant activity of the seeds was attributed to the presence
of flavonoids, as indicated in the report of Kapusta et al.(35).
In 1999, Hübner, Wray and Nahrstedt demonstrated that the
seeds of A. hippocastanum contained glycoside and acylated
forms of quercetin and kaempferol(35,36). In numerous studies,
A. hippocastanum, particularly the seeds(36-39), and its most
common bioactive constituent escin(39-42) were investigated
thoroughly. Escin was found to regulate inflammation mediators through the enhancement of endogenous antioxidative
capacity(42), and was also known to exhibit hepatoprotective
activity by decreasing lipid peroxidation(37,41). Incidentally,
beta-escin was reported to be a natural inhibitor of cell
proliferation and an inducer of apoptosis on acute myeloid
leukemia (HL-60) cells(40). Similarly, beta-escin displayed
antitumor activity on hepatocellular carcinoma in vitro and in
vivo(41). Nevertheless, the scientific bioactivity search for the
rest of this plant was, for the greatest part, left unexplored. On
that account, all the aerial parts of A. hippocastanum besides
the seeds, were investigated for their antioxidant activities.
Particularly, lipid peroxidation inhibitory capacities were
investigated by using sheep liver microsomes mimicking the
physiological biomembranes for the first time in this study.
The seeds were found to contain the lowest amount of phenolics, coinciding with its major constituent saponin(39) which
was not phenolic in structure. The flowers were relatively
low in phenolics and antioxidant capacities. Additionally, the
leaves revealed a high amount of polyphenolic content, but
it was relatively poor in antioxidant capacity. Consequentially, considering all the studied parts, the bark exhibited
an outstanding antioxidant activity, consistent with its high
phenolic content. In literature, plants were inquired as a
source of cancer preventive characteristics in regard to their
polyphenolic contents(40-43). This is the first report on the
antiproliferative effects of the ethanol extract of A. hippocastanum bark on the human breast epitheloid adenocarcinoma
(MCF-7) cells.

CONCLUSIONS
To the best of our knowledge, the aerial parts of A.
hippocastanum were studied, for the first time, regarding their
antioxidant capacities. For all the parts of A. hippocastanum
extracts were found to have antioxidant properties. The bark
extract particularly, revealed the highest antioxidant capacity;
it was also effective to decrease the viability of MCF-7 breast
cancer cells by about 70%. In the preliminary process of
the natural drug discovery, some constituents of the ethanol
extract of A. hippocastanum bark should also be considered
for cytotoxicity studies of different cancer cell lines. Presently, these potentially active constituents of the bark extract
are also under investigation in our laboratory.
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